Zoe M. Weinstein MD,MS, is a general internist and a graduate of the Boston University Addiction Medicine Fellowship. Her research interests include the health of urban underserved patients, especially in the areas of addiction and HIV. Her current clinical work and research are focused on long-term Office-Based Opioid Treatment (OBOT) with buprenorphine, the integration of addiction treatment with primary care and inpatient medical care. She is currently the director of Boston Medical Center’s Addiction Consult Service.
- University of California San Francisco, MD
- Columbia University, BA
- Published on 7/1/2018
Weinstein ZM, Wakeman SE, Nolan S. Inpatient Addiction Consult Service: Expertise for Hospitalized Patients with Complex Addiction Problems. Med Clin North Am. 2018 Jul; 102(4):587-601. PMID: 29933817.
- Published on 6/19/2018
Weinstein ZM, Gryczynski G, Cheng DM, Quinn E, Hui D, Kim HW, Labelle C, Samet JH. Tapering off and returning to buprenorphine maintenance in a primary care Office Based Addiction Treatment (OBAT) program. Drug Alcohol Depend. 2018 Jun 19; 189:166-171. PMID: 29958128.
- Published on 12/1/2017
Mehta AB, Weinstein Z, Walkey AJ. The Untold Toll of the Opioid Crisis on Intensive Care Units in the United States. Ann Am Thorac Soc. 2017 Dec; 14(12):1763-1765. PMID: 29192818.
- Published on 9/9/2017
Schiff DM, Drainoni ML, Weinstein ZM, Chan L, Bair-Merritt M, Rosenbloom D. A police-led addiction treatment referral program in Gloucester, MA: Implementation and participants' experiences. J Subst Abuse Treat. 2017 Nov; 82:41-47. PMID: 29021114.
- Published on 5/16/2017
Hui D, Weinstein ZM, Cheng DM, Quinn E, Kim H, Labelle C, Samet JH. Very early disengagement and subsequent re-engagement in primary care Office Based Opioid Treatment (OBOT) with buprenorphine. J Subst Abuse Treat. 2017 Aug; 79:12-19. PMID: 28673522.
- Published on 5/11/2017
Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, Walley AY. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017 Aug; 79:1-5. PMID: 28673521.
- Published on 12/30/2016
Weinstein ZM, Kim HW, Cheng DM, Quinn E, Hui D, Labelle CT, Drainoni ML, Bachman SS, Samet JH. Long-term retention in Office Based Opioid Treatment with buprenorphine. J Subst Abuse Treat. 2017 Mar; 74:65-70. PMID: 28132702.
- Published on 12/22/2016
Schiff DM, Drainoni ML, Bair-Merritt M, Weinstein Z, Rosenbloom D. A Police-Led Addiction Treatment Referral Program in Massachusetts. N Engl J Med. 2016 12 22; 375(25):2502-2503. PMID: 28002701.
- Published on 11/5/2016
Weinstein ZM, Cheng DM, Quinn E, Hui D, Kim H, Gryczynski G, Samet JH. Psychoactive medications and disengagement from office based opioid treatment (obot) with buprenorphine. Drug Alcohol Depend. 2017 Jan 01; 170:9-16. PMID: 27865152.
- Published on 3/22/2016
Thakarar K, Weinstein ZM, Walley AY. Optimising health and safety of people who inject drugs during transition from acute to outpatient care: narrative review with clinical checklist. Postgrad Med J. 2016 Jun; 92(1088):356-63. PMID: 27004476.
View 1 more publications: View full profile at BUMC